PharmaTech
JANUARY 29, 2025
Pharmaceutical Technology spoke with Saharsh Davuluri, Vice-Chairman and Managing Director, Neuland Laboratories, to see how the push to sustainability is impacting contract manufacturers.
MedCity News
JANUARY 30, 2025
Phase 2 data for Cargo Therapeutics CD22-targeting cell therapy show low durability and cases of a severe immune response, some that were classified as grade 4 or 5 serious adverse events. Cargo is discontinuing the study and shifting focus to a different cell therapy on track to begin Phase 1 testing in mid-2025. The post Safety Risk Sinks Cargo Therapeutics Cancer Cell Therapy Prospect, Leading to 50% Staff Cut appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
JANUARY 27, 2025
Coya Therapeutics is entering into a phase 2b study for its ALS, and the biotech’s CEO believes it’s on the cusp of a game changer.
European Pharmaceutical Review
JANUARY 31, 2025
The National Institute for Health and Care Excellence (NICE) has issued positive final draft guidance for a one-off gene therapy which provides a potential cure for certain patients with severe sickle cell disease. This approval of CASGEVY (exagamglogene autotemcel) is indicated for individuals 12 years and older who have certain types of severe sickle cell disease.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
Eversana Intouch
JANUARY 28, 2025
In a rapidly evolving industry, staying ahead of the curve is critical. In PM360 ‘s article, What Is Pharma Marketing in 2025 ? Angela Tenuta, President, Full-Service Agencies, delves into the transformative trends shaping the future of pharmaceutical marketing. Applied AI Although AI promises a great return on investment, the pharma industry has been slow to adopt it due to ethical, regulatory, and compliance hurdles.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaVoice
JANUARY 27, 2025
These innate immune cells may provide a safer, lower-cost option in cancer and autoimmune diseases.
European Pharmaceutical Review
JANUARY 30, 2025
Christophe Weber is set to retire as Chief Executive Officer (CEO) of Takeda in June 2026 after 12 years.Julie Kim, president of Takedas US Business Unit has been appointed as Webers successor. Weber is the companys current President, CEO and representative director. He joined Takeda as CEO in April 2014. Two months later in June, he transitioned to the role of president and representative director.
Silver Line CRM
JANUARY 30, 2025
Reading time: 3 minutes The pharmaceutical and medtech industries are tackling some of the toughest challenges in healthcare, from improving patient care to navigating complex regulations. Salesforce Life Sciences Cloud is stepping in as a powerful tool to help these industries work smarter, not harder. By combining AI, real-time data, and advanced tools, Life Sciences Cloud creates new opportunities to modernize processes, and Mphasis Silverline is at the forefront of partners innovating on the
MedCity News
JANUARY 28, 2025
Quibims technology applies artificial intelligence analysis to medical images to detect biomarkers. Hospitals and biopharma companies are among the startups customers, using its technology to analyze images to detect disease and guide clinical trial enrollment. The post Medtech Startup Quibim Corrals $50M to Advance AI Analysis in Medical Imaging appeared first on MedCity News.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
PharmaVoice
JANUARY 28, 2025
As changes to the U.S. regulatory foundation take hold, pharmas need to change their strategies to keep innovation — and the bottom line — above the surface.
Quantified
JANUARY 30, 2025
AI was novel in pharma training in early 2024. In 2025, its everywhere. At LTENs last 24 webinars , half had AI in the title. However, not all AI solutions are created equal. Many are little more than chatbots or “thin wrappers”essentially fancy interfaces for ChatGPT or Claude. While these tools have their place, they dont fundamentally transform how sales teams learn, practice, and perform in the field.
David Bagga
JANUARY 25, 2025
Break into Medical device Sales The future of medical sales: trends and predictions The world of medical sales is not static. Innovative technologies connected with the shifting needs of patients create a healthcare environment that demands an ever-innovative solution. This evolution will continue growing. Knowing how things will change while moving ahead, whether you are […] The post future of medical sales trends and predictions appeared first on.
MedCity News
JANUARY 31, 2025
In this episode, were joined by Emily Lindemer, an executive director at Morgan Health. Lindemer discusses a recent report she co-authored, which focuses on maternal health opportunities in employer-sponsored insurance. The post MedCity FemFwd: Comparing Maternal Health in Employer-Sponsored Populations vs. Medicaid appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
PharmaVoice
JANUARY 31, 2025
Despite regulatory uncertainty, pharma is bouncing back from a market slump and is being fueled by innovation.
pharmaphorum
JANUARY 31, 2025
Rare diseases often leave patients, healthcare professionals, and pharma companies navigating complex challenges, from limited treatment options to high costs and difficult clinical trial development. Cell and gene therapies (CGT) offer a unique opportunity to address these challenges by treating diseases at their genetic or cellular roots. In this webinar, sponsored by IPG Health, discover how industry insiders are unlocking the potential of CGT in rare disease care, the unique hurdles facing p
PharmaTimes
JANUARY 28, 2025
Patients and care partners may find once every four weeks maintenance dosing easier
MedCity News
JANUARY 31, 2025
Vertex Pharmaceuticals Jounavx is now FDA approved, providing patients a non-opioid option for treating acute pain. The twice-daily pill is the first in a new class of medicines that block a key pathway in the peripheral nervous system. The post Vertex Pharmas Opioid Alternative Wins FDA Approval, First in a New Class of Pain Meds appeared first on MedCity News.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaVoice
JANUARY 29, 2025
Executive hiring shifts are often indicators of wider trends in the market. Here’s how the hiring landscape for pharma leaders is changing.
pharmaphorum
JANUARY 27, 2025
A GSK alliance with Oxford University aims to identify precancerous changes in cells that could form the basis of preventive vaccines.
Pharmaceutical Technology
JANUARY 31, 2025
The FDA has approved Vertex Pharmaceuticals oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.
MedCity News
JANUARY 30, 2025
As the pool of approved therapies continues to (hopefully) expand, the clinical and diagnostic testing communities need to do a better job at ensuring the right patients move through this journey more quickly and accurately to improve their health and prognosis. The post Why Blood is Best: Transforming the Diagnostic Journey for Alzheimer’s Disease appeared first on MedCity News.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
PharmaVoice
JANUARY 29, 2025
Vertex Pharmaceuticals’ non-opioid pain medication is up for FDA approval this week. Other drugmakers have found safer alternatives to expand the pain management landscape.
pharmaphorum
JANUARY 27, 2025
Pfizer has paid $60m to settle US government allegations that its Biohaven unit made improper payments to prescribers of its migraine drug Nurtec ODT.
Pharmaceutical Technology
JANUARY 31, 2025
Sanofi has announced an increase in net income from continuing operations for the fourth quarter (Q4) of 2024, reaching 880m ($833m).
MedCity News
JANUARY 30, 2025
By insisting on coding-aware AI solutions, health systems can ensure that these technologies fulfill their transformative promise, reducing clinician burnout and administrative burden, improving patient care and communication, and accurately capturing what occurred during an encounter. The post The Most Overlooked Feature with AI Scribes: Coding Awareness appeared first on MedCity News.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
PharmaVoice
JANUARY 30, 2025
“Are you supportive of these onesies?” Sen. Bernie Sanders asked Kennedy, pointing to infant clothing stamped with anti-vaccine slogans — and more from yesterday’s confirmation hearing.
PharmaTech
JANUARY 29, 2025
Pharmaceutical Technology spoke with Adam Sherlock, CEO of Qinecsa, about the industry trends of 2024, the future technology agenda, and M&A prospects in 2025.
Pharmaceutical Technology
JANUARY 27, 2025
Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for preferential prescriptions.
Expert insights. Personalized for you.
106 
Let's personalize your content